证券代码：688236 证券简称：春立医疗 公告编号：2025-048 北京市春立正达医疗器械股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 由于有意出席2025年第二次H股类别股东大会的H股持有人所持有的附投票权 H股数目未能达到本公司 章程所规定在H股类别股东大会（续会除外）上附投票权H股总数的三分之一或以上，公司拟定在2025 年11月19日下午举行的2025年第二次H股类别股东大会推迟至2025年12月3日上午举行。涉及类别股东 大会审议的《关于取消监事会并修订〈公司章程〉〈股东会议事规则〉及〈董事会议事规则〉的议 案》，此议案需经过2025年第一次临时股东大会、2025年第二次A股类别股东大会、2025年第二次H股 类别股东大会上述3个股东大会出席会议的股东分别投票，针对此议案需经每个股东大会出席该会议股 东所持表决权的三分之二以上审议通过。因此，在2025年第二次H股类别股东大会股东审议完成后，才 可确认此议案是否通过，敬请投资人关注相关公告信息。 ...

Meeting Details - The shareholder meeting is scheduled for November 18, 2025, at 14:30, with online voting available from 9:15 to 15:00 on the same day [3][4][6] - The meeting will be held at the conference room on the third floor of He Ying Center, No. 10, Xiaoying West Road, Haidian District, Beijing [4] - The meeting is convened by the company's board of directors and will be presided over by Chairman Zhang Deqiang [5][7] Attendance and Voting - A total of 622 shareholders and authorized representatives attended, representing 583,772,101 shares, which is 41.7937% of the total voting shares [8] - Among them, 2 shareholders voted in person, representing 427,350,097 shares (30.5950%), while 620 shareholders voted online, representing 156,422,004 shares (11.1986%) [8] - Small shareholders accounted for 1.7677% of the total voting shares, with 619 participating online [8] Resolutions Passed - The following resolutions were approved during the meeting: - Amendment to the Articles of Association: 98.7031% in favor [12] - Revision of the Shareholders' Meeting Rules: 97.4894% in favor [14] - Revision of the Board Meeting Rules: 97.4878% in favor [16] - Independent Director System: 97.4901% in favor [19] - Related Party Transaction Decision-Making System: 97.4657% in favor [22] - External Guarantee Decision-Making System: 97.4493% in favor [25] - External Investment Management System: 97.4896% in favor [28] - Major Transaction Decision-Making System: 97.4890% in favor [31] - Fundraising Management System: 97.4899% in favor [34] - Purchase of Directors and Officers Liability Insurance: 96.9166% in favor [37] Legal Opinion - The legal representatives from Beijing Junzhi Law Firm confirmed that the meeting's procedures and resolutions complied with relevant laws and regulations, making the decisions valid [39]

Core Points - The company held its second extraordinary general meeting of shareholders in 2025 on November 17, 2025, with a total of 611 shareholders present, representing 1,023,280,293 shares, which is 54.1306% of the total voting shares [9][11]. Meeting Details - The meeting was conducted both in-person and via online voting, with specific time slots for each method [6][4]. - The location of the in-person meeting was at 655 Zhongchen Road, Songjiang District, Shanghai [5]. Voting Results - Proposal 1: Amendment to the Articles of Association was approved with 99.9911% in favor [12]. - Proposal 2: Amendment to the Rules of Procedure for Shareholders' Meetings was approved with 87.4303% in favor [15]. - Proposal 3: Amendment to the Rules of Procedure for Board Meetings was approved with 87.4292% in favor [17]. - Proposal 4: Amendment to the Independent Director Work System was approved with 87.4287% in favor [20]. - Proposal 5: Amendment to the Related Party Transaction Management System was approved with 87.4308% in favor [21]. - Proposal 6: Amendment to the Information Disclosure Management System was approved with 87.4309% in favor [22]. - Proposal 7: Amendment to the Fundraising Management System was approved with 87.4310% in favor [23]. - Proposal 8: Amendment to the Donation Management System was approved with 87.4306% in favor [24]. - Proposal 9: Establishment of the Compensation Management System for Directors and Senior Management was approved with 99.9921% in favor [26]. Legal Opinion - The legal opinion provided by Guohao Law Firm confirmed that the meeting was convened and conducted in accordance with relevant laws and regulations, and the voting results were deemed valid [25]. Documentation - The resolutions from the meeting and the legal opinion are available for review [27].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603016 证券简称：新宏泰 公告编号：2025-033 无锡新宏泰电器科技股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 二、议案审议情况 (一)股东会召开的时间：2025年11月13日 (二)股东会召开的地点：江苏省无锡市惠山区堰新路18号新宏泰402会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 本次会议的召集、召开程序及出席会议人员的资格均符合《公司法》和《公司章程》的规定。会议由丁 奎先生主持，以现场投票和网络投票相结合的方式表决通过本次股东大会的议案。 (五)公司董事和董事会秘书的出席情况 1、公司在任董事7人，出席7人； 2、董事会秘书杜建平先生出席会议，财务总监高岩敏女士、副总经理沈华女士、陈靛洁女士列席会 议。 (一)非 ...

Group 1 - The first extraordinary general meeting of shareholders for 2025 was held on November 12, 2025, at the comprehensive service building of Guangzhou Baiyun International Airport [2] - The meeting was convened by the board of directors and presided over by the chairman and general manager, Mr. Wang Xiaoyong, in compliance with the Company Law and the company's articles of association [2][3] - A total of 6 out of 7 current directors attended the meeting, along with all 3 supervisors and the board secretary [3] Group 2 - All proposed resolutions were approved without any dissenting votes, including the appointment of financial and internal control audit institutions for 2025 [4][5] - The meeting also approved amendments to the company's articles of association and various internal rules, including the rules for shareholder meetings and board meetings [5] - The resolutions were passed with the required majority, with ordinary resolutions needing over half of the voting rights and special resolutions requiring two-thirds [5] Group 3 - The meeting was witnessed by Beijing Fenxun Law Firm, with lawyers confirming that the procedures followed were in accordance with relevant laws and regulations [6]

Financial Data and Key Metrics Changes - The total shares voted were at least 24.8 million shares, representing at least 68% of the issued and outstanding shares as of the record date, confirming a quorum for the transaction of business [11] - In the matter of the election of 10 directors, each nominee received at least 22 million votes, indicating substantial majority support [11] - At least 98% of shareholders voted in favor of the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year [11] - Over 86% of shareholders voted in favor of the advisory vote on executive compensation of Adtalem's named executive officers [11] Business Line Data and Key Metrics Changes - No specific data on business line performance or key metrics was provided in the meeting records Market Data and Key Metrics Changes - No specific market data or key metrics changes were discussed in the meeting records Company Strategy and Development Direction and Industry Competition - The company continues to focus on maintaining strong governance with the election of directors and the ratification of independent auditors, which reflects a commitment to transparency and accountability [6][12] - The advisory vote on executive compensation indicates a focus on aligning management incentives with shareholder interests [9][10] Management's Comments on Operating Environment and Future Outlook - No specific comments from management regarding the operating environment or future outlook were provided in the meeting records Other Important Information - The meeting was conducted virtually, and a support line was available for technical difficulties [1] - The company expressed appreciation to shareholders for their participation and proxy submissions [4] Q&A Session Summary - No questions were submitted during the Q&A session, and the meeting concluded without any additional inquiries [14]

Core Points - The Shanghai Data Port Co., Ltd. held its second extraordinary general meeting of shareholders in 2025 on November 11, 2025 [2][8] - The meeting was chaired by Chairman Sun Zhongfeng and combined on-site and online voting methods, complying with the Company Law and the company's articles of association [2][3] - All resolutions proposed during the meeting were approved without any dissenting votes [4][5] Meeting Attendance - Out of 9 current directors, 6 attended the meeting, while 3 independent directors were absent due to work commitments [3] - Among 5 current supervisors, 2 attended, with 3 absent for similar reasons [3] - The company secretary and all senior management were present at the meeting [3] Resolutions Reviewed - The following resolutions were passed: 1. Proposal to cancel the supervisory board and amend certain provisions of the articles of association [4] 2. Proposal to appoint the accounting firm for the fiscal year 2025 [4] 3. Proposal to amend the rules of procedure for board meetings [5] 4. Proposal to amend the rules of procedure for shareholder meetings [5] 5. Proposal to amend the management measures for the use of raised funds [5] - The first proposal required a special resolution and was approved by more than two-thirds of the voting rights present at the meeting [5] Legal Verification - The meeting was witnessed by Guohao Law Firm, with lawyers Cao Jiangwei and Xu Xuehua confirming that the meeting complied with legal and regulatory requirements [6] - The qualifications of attendees and the convenor were deemed valid, and the voting procedures and results were confirmed to be in accordance with relevant laws and the company's articles of association [6]

Group 1 - The second extraordinary general meeting of shareholders was held on November 5, 2025, in Shantou, Guangdong Province [2] - All directors and supervisors attended the meeting, with no absences reported [3] - The meeting adopted several resolutions, including changing the company name, stock abbreviation, and registered address [4][5] Group 2 - The company name will change to "Quzhou Dongfeng New Materials Group Co., Ltd." and the stock abbreviation will change to "Quzhou Dongfeng," effective November 11, 2025 [8][10] - The changes are due to a shift in the controlling shareholder and are intended to align the stock abbreviation with the new company name and registered address [9] - The stock code "601515" will remain unchanged [10]

Meeting Overview - The company held its first extraordinary general meeting of shareholders on October 30, 2025, as announced on October 15, 2025 [4][5]. - The meeting was conducted both in-person and via online voting, with a total of 63 shareholders present, representing 29,842,366 shares, which is 49.4238% of the total voting shares [10]. Voting Results - The following proposals were approved during the meeting: 1. Amendment to the Articles of Association: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [14][15]. 2. Amendment to the Rules of Procedure for Shareholders' Meetings: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [18][19]. 3. Amendment to the Rules of Procedure for Board Meetings: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [22][23]. 4. Amendment to the Independent Director Work Rules: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [24][25]. 5. Amendment to the Related Party Transaction Management System: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [27][28]. 6. Amendment to the External Investment Management System: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [30][31]. 7. Amendment to the External Guarantee Management System: - Votes in favor: 29,821,366 shares (99.9296%) - Votes against: 18,900 shares (0.0633%) - Abstentions: 2,100 shares (0.0070%) [33][34]. 8. Amendment to the Fundraising Management System: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [36][37]. 9. Amendment to the Controlling Shareholder Behavior Norms: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [39][40]. 10. Amendment to the Investor Relations Management System: - Votes in favor: 29,821,466 shares (99.9300%) - Votes against: 18,800 shares (0.0630%) - Abstentions: 2,100 shares (0.0070%) [42][43]. 11. Amendment to the Selection System for Accounting Firms: - Votes in favor: 29,815,766 shares (99.9109%) - Votes against: 17,700 shares (0.0593%) - Abstentions: 8,900 shares (0.0298%) [45][46]. Legal Compliance - The meeting was witnessed by lawyers from Guohao Law Firm, who confirmed that the notice, convening, and voting procedures complied with relevant laws and regulations [47]. Documentation - The resolutions from the first extraordinary general meeting and the legal opinion from Guohao Law Firm are available for review [48].

Group 1 - The third extraordinary general meeting of shareholders of Shanxi Lu'an Chemical Technology Co., Ltd. was held on October 31, 2025, at the Lu'an Days Hotel in Taiyuan, Shanxi Province [2][3] - The meeting was presided over by Chairman Ma Junxiang, with 7 out of 9 directors and 4 out of 5 supervisors present [3][6] - All resolutions proposed during the meeting were approved without any dissenting votes [2][4] Group 2 - The first resolution involved signing a financial service agreement with Lu'an Group Finance Co., Ltd., which was approved [4] - The second resolution regarding the amendment of the company's articles of association and the cancellation of the supervisory board was passed as a special resolution, requiring more than two-thirds of the voting rights [5][6] - Other resolutions included amendments to the rules of procedure for shareholder meetings, board meetings, and independent director work systems, all of which were approved [5]